BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng HY, Li G, Luo J, Li XR, Alai G, Lin YD. The Role of Surgery in Treating Resectable Limited Disease of Esophageal Neuroendocrine Carcinoma. World J Surg. 2018;42:2428-2436. [PMID: 29340724 DOI: 10.1007/s00268-018-4475-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang G, Li J. Reply to the Editor: how to treat esophageal neuroendocrine carcinoma with proper stratification? Dis Esophagus 2019;32:doz036. [PMID: 31022728 DOI: 10.1093/dote/doz036] [Reference Citation Analysis]
2 Honma Y, Nagashima K, Hirano H, Shoji H, Iwasa S, Takashima A, Okita N, Kato K, Boku N, Murakami N, Inaba K, Ito Y, Itami J, Kanamori J, Oguma J, Daiko H. Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy. Cancer Med. 2020;9:595-604. [PMID: 31794158 DOI: 10.1002/cam4.2708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhou Y, Hou P, Zha KJ, Wang F, Zhou K, He W, Gao JB. Prognostic value of pretreatment contrast-enhanced computed tomography in esophageal neuroendocrine carcinoma: A multi-center follow-up study. World J Gastroenterol 2020; 26(31): 4680-4693 [PMID: 32884225 DOI: 10.3748/wjg.v26.i31.4680] [Reference Citation Analysis]
4 Merola E, Rinke A, Partelli S, Gress TM, Andreasi V, Kollár A, Perren A, Christ E, Panzuto F, Pascher A, Jann H, Arsenic R, Cremer B, Kaemmerer D, Kump P, Lipp RW, Agaimy A, Wiedenmann B, Falconi M, Pavel ME. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? Ann Surg Oncol 2020;27:1348-55. [PMID: 31720931 DOI: 10.1245/s10434-019-08049-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
5 Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol 2021;56:1033-44. [PMID: 34586495 DOI: 10.1007/s00535-021-01827-7] [Reference Citation Analysis]
6 Liu L, Liu Y, Gong L, Zhang M, Wu W. Salvage camrelizumab plus apatinib for relapsed esophageal neuroendocrine carcinoma after esophagectomy: a case report and review of the literature. Cancer Biol Ther 2020;21:983-9. [PMID: 33092443 DOI: 10.1080/15384047.2020.1829265] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhang G, Wu B, Wang X, Li J. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma. Dis Esophagus. 2019;32:doy129. [PMID: 30715226 DOI: 10.1093/dote/doy129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Liu M, Popa EC, Finnerty BM, Fahey TJ 3rd, Zarnegar R. Clinicopathological Features of Gastroesophageal Neuroendocrine Neoplasms. Curr Gastroenterol Rep 2020;22:50. [PMID: 32797314 DOI: 10.1007/s11894-020-00788-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wang H, Chen Y, Pi G, Zhu Y, Yang S, Mei H, Lin Z, Zhang T. Validation and proposed modification of the 8th edition American Joint Committee on Cancer staging system for patients with esophageal neuroendocrine neoplasms: Evaluation of a revised lymph node classification. Oncol Lett. 2020;19:4122-4132. [PMID: 32382351 DOI: 10.3892/ol.2020.11480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Wang MM, Singh SK. Rapidly Extensive Recurrence of Esophageal Neuroendocrine Carcinoma After Complete Pathologic Response to Definitive Chemoradiation. ACG Case Rep J 2022;9:e00730. [DOI: 10.14309/crj.0000000000000730] [Reference Citation Analysis]
11 Merola E, Falconi M, Rinke A, Staettner S, Krendl F, Partelli S, Andreasi V, Gress TM, Pascher A, Arsenic R, Doglioni C, Kaemmerer D, Wiedenmann B, Pavel ME. Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3. The American Journal of Surgery 2020;220:284-9. [DOI: 10.1016/j.amjsurg.2020.03.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
12 Deng HY. How to treat esophageal neuroendocrine carcinoma with proper stratification? Dis Esophagus 2019;32:doz035. [PMID: 31022730 DOI: 10.1093/dote/doz035] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Deng HY. Is There a Role for Surgery in Treating Localized Esophageal Neuroendocrine Tumor? Ann Surg Oncol 2020;27:960-1. [PMID: 31828688 DOI: 10.1245/s10434-019-08118-9] [Reference Citation Analysis]
14 Chen C, Hu H, Zheng Z, Yang Y, Chen W, Qiao X, Li P, Zhang S. Clinical characteristics, prognostic factors, and survival trends in esophageal neuroendocrine carcinomas: A population-based study. Cancer Med 2022. [PMID: 35596661 DOI: 10.1002/cam4.4829] [Reference Citation Analysis]
15 Morita M, Taguchi K, Kagawa M, Nakanoko T, Uehara H, Sugiyama M, Ota M, Ikebe M, Sugimachi K, Esaki T, Toh Y. Treatment strategies for neuroendocrine carcinoma of the upper digestive tract. Int J Clin Oncol. 2020;25:842-850. [PMID: 32036480 DOI: 10.1007/s10147-020-01631-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ishikawa-Kakiya Y, Nagami Y, Fujiwara Y. Intramucosal esophageal neuroendocrine carcinoma treated with endoscopic submucosal dissection and chemotherapy. Dig Endosc 2019;31:466. [PMID: 30977209 DOI: 10.1111/den.13420] [Reference Citation Analysis]